Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum

Por Yi, J H, Lee, J, Lee, J, Park, S H, Park, J O, Yim, D-S, Park, Y S, Lim, H Y, Kang, W K
Publicado em 2012

MAP2K1 Mutation in Colorectal Cancer Patients: Therapeutic Challenge Using Patient-Derived Tumor Cell Lines

Por Kim, J. E., Kim, K.K., Kim, S. Y., Lee, J., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Kang, W. K., Kim, S. T.
Publicado no J Cancer (2017)

Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer

Por Hong, Y S, Lee, H R, Park, S, Lee, S C, Hwang, I G, Park, B-B, Lee, J, Ahn, J S, Ahn, M-J, Lim, H Y, Park, K
Publicado em 2006

Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvan...

Por Choi, J-H, Lim, H-Y, Joo, H J, Kim, H S, Yi, J W, Kim, H C, Cho, Y K, Kim, M W, Lee, K B
Publicado em 2002

Comparison of p53 gene mutations in paired primary and metastatic gastric tumor tissues.

Por Kim, J. H., Choi, J. J., Noh, S. H., Roh, J. K., Min, J. S., Youn, J. K., Yoo, N. C., Lim, H. Y., Carbone, D. P., Gazdar, A. F.
Publicado em 1993

Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours

Por Ahn, H K, Choi, J Y, Kim, K-M, Kim, H, Choi, S-H, Park, S H, Park, J O, Lim, H Y, Kang, W K, Lee, J, Park, Y S
Publicado em 2013

Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

Por Choi, J-H, Lim, H-Y, Nam, D K, Kim, H S, Cho, D Y, Yi, J W, Kim, H C, Cho, Y K, Kim, M W, Joo, H J, Lee, K B, Kim, K B
Publicado em 2001

Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial

Por Escudier, B, Michaelson, M D, Motzer, R J, Hutson, T E, Clark, J I, Lim, H Y, Porfiri, E, Zalewski, P, Kannourakis, G, Staehler, M, Tarazi, J, Rosbrook, B, Cisar, L, Hariharan, S, Kim, S, Rini, B I
Publicado em 2014

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer

Por Lim, S H, Kim, T W, Hong, Y S, Han, S-W, Lee, K-H, Kang, H J, Hwang, I G, Lee, J Y, Kim, H S, Kim, S T, Lee, J, Park, J O, Park, S H, Park, Y S, Lim, H Y, Jung, S-H, Kang, W K
Publicado no Br J Cancer (2015)

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients

Por Kim, S T, Banks, K C, Pectasides, E, Kim, S Y, Kim, K, Lanman, R B, Talasaz, A, An, J, Choi, M G, Lee, J H, Sohn, T S, Bae, J M, Kim, S, Park, S H, Park, J O, Park, Y S, Lim, H Y, Kim, N K D, Park, W, Lee, H, Bass, A J, Kim, K, Kang, W K, Lee, J
Publicado no Ann Oncol (2018)